Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy?
J Thorac Dis
.
2020 Aug;12(8):4549-4552.
doi: 10.21037/jtd-20-1672.
Authors
Toyoaki Hida
1
,
Teppei Yamaguchi
1
Affiliation
1
Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
PMID:
32944372
PMCID:
PMC7475526
DOI:
10.21037/jtd-20-1672
No abstract available
Publication types
Editorial
Comment